4//SEC Filing
Murray Christopher K. 4
Accession 0001415889-24-006954
CIK 0001597264other
Filed
Mar 5, 7:00 PM ET
Accepted
Mar 6, 10:41 AM ET
Size
16.6 KB
Accession
0001415889-24-006954
Insider Transaction Report
Form 4
Murray Christopher K.
SVP, Technical Operations
Transactions
- Award
Common Stock
2024-03-01+12,500→ 36,995 total - Sale
Common Stock
2024-03-04$93.65/sh−621$58,157→ 36,374 total - Award
Stock Option (Right to Buy)
2024-03-01+25,000→ 25,000 totalExercise: $95.12Exp: 2034-03-01→ Common Stock (25,000 underlying)
Footnotes (3)
- [F1]The reported transaction involved the Reporting Person's receipt of grant of 12,500 restricted stock units under Issuer's 2015 Stock Option and Incentive Plan.
- [F2]Effected pursuant to a trading plan adopted on June 5, 2023 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- [F3]This option vests with respect to 1/48th of the shares underlying the option on April 1, 2024 and as to an additional 1/48th of the shares underlying the option each month thereafter.
Documents
Issuer
Blueprint Medicines Corp
CIK 0001597264
Entity typeother
Related Parties
1- filerCIK 0001718648
Filing Metadata
- Form type
- 4
- Filed
- Mar 5, 7:00 PM ET
- Accepted
- Mar 6, 10:41 AM ET
- Size
- 16.6 KB